Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1961 Sep;53(5):456-462, 492.

Mechanism of Formation of Vascular Thrombosis and its Treatment With Fibrinolysin *,†,§

Eugene E Cliffton
PMCID: PMC2641990  PMID: 13694112

Full text

PDF
456

Images in this article

460Figs. 5 & 6
on p.460

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AMBRUS C. M., MARKUS G. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. Am J Physiol. 1960 Sep;199:491–494. doi: 10.1152/ajplegacy.1960.199.3.491. [DOI] [PubMed] [Google Scholar]
  3. ASTRUP T. Fibrinolysis in the organism. Blood. 1956 Sep;11(9):781–806. [PubMed] [Google Scholar]
  4. BACH N., AMBRUS J. L., SIMPSON C. L., SHULMAN S. Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J Clin Invest. 1958 Jun;37(6):864–871. doi: 10.1172/JCI103677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CLIFFTON E. E. Fibrinolysin as an agent for treatment of thromboembolic accidents. JAMA. 1961 Jan 28;175:302–306. doi: 10.1001/jama.1961.63040040001007. [DOI] [PubMed] [Google Scholar]
  6. CLIFFTON E. E. The use of plasmin in humans. Ann N Y Acad Sci. 1957 Aug 30;68(1):209–229. doi: 10.1111/j.1749-6632.1957.tb42627.x. [DOI] [PubMed] [Google Scholar]
  7. CLIFFTON E. E. Variations in the proteolytic and the antiproteolytic reactions of serum: effect of disease, trauma, x-ray, anaphylactic shock, ACTH, and cortisone. J Lab Clin Med. 1952 Jan;39(1):105–121. [PubMed] [Google Scholar]
  8. FREIMAN A. H., BANG N. U., CLIFFTON E. E. Studies on the production of intravascular thrombi and their treatment with fibrinolysin. Circ Res. 1960 Mar;8:409–418. doi: 10.1161/01.res.8.2.409. [DOI] [PubMed] [Google Scholar]
  9. FREIMAN A. H., CLIFFTON E. E. The effect of fibrinogen concentration on susceptibility of clots to in vitro clot lysis with plasmin. Thromb Diath Haemorrh. 1958 Sep 1;2(3-4):269–278. [PubMed] [Google Scholar]
  10. GROSSI C. E., CLIFFTON E. E. The lysis of arterial thrombi in rabbits and dogs by use of activated human plasminogen (fibrinolysin) (plasmin). Surgery. 1955 May;37(5):794–802. [PubMed] [Google Scholar]
  11. HERNDON R. M., MEYER J. S., JOHNSON J. F., LANDERS J. Treatment of cerebrovascular thrombosis with fibrinolysin. Preliminary report. Am J Cardiol. 1960 Aug;6:540–545. doi: 10.1016/0002-9149(60)90350-7. [DOI] [PubMed] [Google Scholar]
  12. RUEGSEGGER P., NYDICK I., ABARQUEZ R., REICHEL F., CLIFFTON E. E., LADUE J. S. Effect of fibrinolytic (plasmin) therapy on the physiopathology of myocardial infarction. Am J Cardiol. 1960 Aug;6:519–524. doi: 10.1016/0002-9149(60)90347-7. [DOI] [PubMed] [Google Scholar]
  13. Tillett W. S., Edwards L. B., Garner R. L. FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS. J Clin Invest. 1934 Jan;13(1):47–78. doi: 10.1172/JCI100579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yamakawa S. THE AUTODIGESTION OF NORMAL SERUM THROUGH THE ACTION OF CERTAIN CHEMICAL AGENTS. I. J Exp Med. 1918 Jun 1;27(6):689–710. doi: 10.1084/jem.27.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES